Skip to content

Menu

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

CureVac

Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents

Jennifer Tacker / 8 October 2024

LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two […]

Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents Read More »

GSK

GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac

Zabih Ullah / 3 July 2024

On Wednesday, British drugmaker GSK (NYSE: GSK) bought partner CureVac (NASDAQ: CVAC) out of their alliance on influenza and COVID-19

GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac Read More »

Company

Become A Contributor

Categories

Legal

Editorial Policy

Modern Slavery Statement

Anti Bribery And Corruption Policy

Top Tech Stocks 2024

Top Bank Stocks 2024

Worst Stocks 2024

We Are Licensed Partners Of Reuters

Copyright © 2024 abbonews.com